Dr. Aaron Pawlyk received his PhD in 2001 in the lab of Dr. Donald Pettigrew. He is a Program Director at the National Institute of Diabetes and Digestive and Kidney Diseases at the National Institutes of Heatlh. His job responsibilities include oversight of grants going to universities, scientific management of large NIH-funded consortia, and providing strategic vision for the NIH. The Illuminating the Druggable Genome program, which Dr. Pawlyk serve as Coordinator, has recently transitioned to its implementation phase. This exciting project will identify important functions for understudied proteins in protein families that are know to be druggable and therefore have a high likelihood to impact human health. Additionally, Dr. Pawlyk oversee the NIH-funded portion of the Accelerating Medicines Partnership for Type 2 Diabetes program. This program is leveraging extensive studies of the genetics of type 2 diabetes to explore new areas of biology with the potential to identify viable drug targets for Type 2 diabetes.
Dr. Pawlyk’s advice to current graduate students:
“Focus on what nature is revealing to you through science and follow the path it illuminates.”